Milton Friedman's 1980 call to abolish the NIH resurfaces in market-oriented critique
By
Scott Atlas
Summary
A brief opinion piece citing economist Milton Friedman's 1980 call to abolish the National Institutes of Health (NIH) and the National Science Foundation (NSF), arguing that the $48 billion government research monopoly should be replaced by market forces — or "nothing" at all.
Source

Key quotes
· 3 pulledIn 1980, economist Milton Friedman said the National Institutes of Health should be abolished.
Friedman said the same about another government research agency, the National Science Foundation.
And when he was asked what the NSF should be replaced with, he replied: 'Nothing.'
You might also wanna read
Terminated NIH Grants on LGBTQ+ Health Reveal Deeper Threats to Scientific Independence
This article examines the lasting damage caused by the termination of NIH grants targeting LGBTQ+ health research, focusing on the case of e
A Free-Market Perspective on Reducing Healthcare Costs
The article presents a free-market perspective on healthcare reform, arguing that healthcare costs are driven by expenses for personnel, dru
OMB Proposal to Rewrite Federal Grant Rules Threatens US Scientific Research Enterprise
The article discusses a critical policy change proposed by the Office of Management and Budget to rewrite 2 CFR Part 200, the rule governing
Defend Public Health Urges Congress to Block OMB Rules on Federal Research Grants
Defend Public Health is urging Congress to block new OMB regulations on federal research grants, arguing the rules eliminate independent pee
How the AMA's Post-WWII Campaign Undermined National Health Insurance in the United States
This study examines how the American Medical Association (AMA) shaped the U.S. health insurance system after World War II by launching a nat
Analysis of the Trump Administration's Dismantling of American Scientific Institutions
The article discusses how the second Trump administration has systematically dismantled American scientific institutions over 16 months, inc

Comments
Sign in to join the conversation.
No comments yet. Be the first.